PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
When do Propranolol Hydrochloride And Hydrochlorothiazide patents expire, and what generic alternatives are available?
Propranolol Hydrochloride And Hydrochlorothiazide is a drug marketed by Actavis Elizabeth, Ani Pharms, Chartwell Rx, Ivax Sub Teva Pharms, Rising, Warner Chilcott, and Watson Labs. and is included in fifteen NDAs.
The generic ingredient in PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; propranolol hydrochloride. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; propranolol hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE?
- What are the global sales for PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE?
- What is Average Wholesale Price for PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE?
Summary for PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
US Patents: | 0 |
Applicants: | 7 |
NDAs: | 15 |
Clinical Trials: | 1 |
DailyMed Link: | PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE at DailyMed |
Recent Clinical Trials for PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
VA Office of Research and Development | |
US Department of Veterans Affairs |
See all PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE clinical trials